InnoTherapy Inc Total Liabilities

Latest as of September 2025: ₩50.78 Billion KRW ≈ $34.41 Million USD

InnoTherapy Inc total liabilities. Based on the latest financial reports, InnoTherapy Inc (246960) has total liabilities worth ₩50.78 Billion KRW (≈ $34.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 246960 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of InnoTherapy Inc (2015–2024)

Total liabilities of InnoTherapy Inc from 2015 to 2024. This chart illustrates how InnoTherapy Inc's total liabilities have evolved over time, based on quarterly financial data. Explore InnoTherapy Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

InnoTherapy Inc Competitors by Total Liabilities

The table below lists competitors of InnoTherapy Inc ranked by their total liabilities.

Company Country Total Liabilities
Canaf Investments Inc
V:CAF
Canada CA$2.07 Million
Repower Asia Indonesia PT
JK:REAL
Indonesia Rp2.06 Billion
Managepay Systems Bhd
KLSE:0156
Malaysia RM14.03 Million
MMAG Holdings Bhd
KLSE:0034
Malaysia RM566.18 Million
Schroder Oriental Income Fund
LSE:SOI
UK GBX44.42 Million
Pure Resources Ltd
AU:PR1
Australia AU$476.80K
Chuan Huat Resources Bhd
KLSE:7016
Malaysia RM319.65 Million
aXichem AB
ST:AXIC-A
Sweden Skr9.69 Million

Liability Composition Analysis (2015–2024)

This chart breaks down InnoTherapy Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see InnoTherapy Inc total assets.

Liquidity & Leverage Metrics

InnoTherapy Inc Total Liabilities Ratios Explained

InnoTherapy Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.98 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.96 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.67 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how InnoTherapy Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for InnoTherapy Inc (2015–2024)

The table below shows the annual total liabilities of InnoTherapy Inc from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 ₩8.54 Billion
≈ $5.79 Million
-24.12%
2023-12-31 ₩11.26 Billion
≈ $7.63 Million
-36.66%
2022-12-31 ₩17.77 Billion
≈ $12.04 Million
-18.50%
2021-12-31 ₩21.80 Billion
≈ $14.78 Million
+394.60%
2020-12-31 ₩4.41 Billion
≈ $2.99 Million
+105.02%
2019-12-31 ₩2.15 Billion
≈ $1.46 Million
+29.66%
2018-12-31 ₩1.66 Billion
≈ $1.12 Million
+49.76%
2017-12-31 ₩1.11 Billion
≈ $750.44K
+15.60%
2016-12-31 ₩957.90 Million
≈ $649.16K
-93.32%
2015-12-31 ₩14.34 Billion
≈ $9.72 Million
--

About InnoTherapy Inc

KQ:246960 Korea Medical Devices
Market Cap
$11.65 Million
₩17.20 Billion KRW
Market Cap Rank
#26520 Global
#2002 in Korea
Share Price
₩2025.00
Change (1 day)
-6.47%
52-Week Range
₩1440.00 - ₩2875.00
All Time High
₩25350.00
About

SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasi… Read more